Objective: We sought to quantify absorption of triclosan, a potential endocrine disruptor, in health care workers with occupational exposure to soap containing this chemical. Methods: A cross-sectional convenience sample of two groups of 38 health care workers at separate inpatient medical centers: hospital 1 uses 0.3% triclosan soap in all patient care areas; hospital 2 does not use triclosan-containing products. Additional exposure to triclosancontaining personal care products was assessed through a structured questionnaire. Urine triclosan was quantified and the occupational contribution estimated through regression modeling. Results: Occupational exposure accounted for an incremental triclosan burden of 206 ng/mL (P = 0.02), while triclosan-containing toothpaste use was associated with 146 ng/mL higher levels (P < 0.001). Conclusions: Use of triclosan-containing antibacterial soaps in health care settings represents a substantial and potentially biologically relevant source of occupational triclosan exposure.
Most liquid soaps sold in the United States contain triclosan. 3 Occupational sources represent a potentially important exposure scenario because some, albeit not all, health care institutions commonly use triclosan-containing antibacterial soaps and because frequent hand washing among health care workers in such environments (range, 0.7 to 30 times per hour) 4 is likely to facilitate triclosan exposure. A growing body of scientific research calls into question the safety of triclosan. For example, in vivo and in vitro studies have shown endocrine effects such as thyroid hormone disruption [5] [6] [7] and perturbation of sex hormone homeostasis. [8] [9] [10] [11] [12] [13] [14] In addition, triclosan exposure may impair muscle function in animal models 15 and also has been associated with hay fever or allergies in humans. 16, 17 Despite these potential effects, human toxicity from triclosan has not been established or excluded, and thus, this chemical has been tentatively categorized as having "insufficient evidence to classify as safe or effective" (category IIISE) by the US Food and Drug Administration. 18 Addressing this knowledge gap, the US Food and Drug Administration recently proposed to include triclosan among a group of antibacterial products requiring additional safety data and demonstration of clinical benefit over the use of plain soap. 18 Triclosan is absorbed after transdermal or oral exposure. Quantification of triclosan in urine represents a key biomonitoring instrument for such absorption, because triclosan (as free and conjugated metabolites) is excreted primarily in urine, with a half-life of about 11 hours in humans. 19, 20 In 2003 and 2004, a US populationbased sample (n = 2517) in the National Health and Nutrition Examination Survey (NHANES) showed that 75% had detectable urine triclosan levels. 21 Limited (n = 91) but more recent biomonitoring data from California found that triclosan was detectable in 95% of the samples tested. 22 Given the potential adverse human health effects of triclosan, better characterization of exposure risks is warranted. We hypothesized that biomonitoring would establish that the burden of triclosan in health care workers is indeed higher because of occupational exposure and that, among such persons, personal care product would superimpose even greater exposure. To test this, we compared urine triclosan levels among physicians and nurses at two hospitals in close geographic proximity: one that uses triclosan-containing handwashing soap and one that does not.
METHODS

Design and Subjects
We carried out a cross-sectional study in a convenience sample of physicians and nurses at two hospitals. Hospital 1 uses a 0.3% triclosan-based soap in all patient care areas and restrooms (staff and public). Hospital 2 uses plain soap and water, having previously phased out triclosan-containing soaps. Both hospital sites also have a water-free alcohol-based hand rub for hand hygiene (a product that does not contain triclosan). To be eligible for study inclusion, participants were required to be a physician (doctor of medicine or doctor of osteopathic medicine) or a nurse (registered nurse) employed on a full-time basis at their hospital site (defined as regularly working 36 or more hours per week) and to have worked at least 8 of the 48 hours before study recruitment. Potential subjects also were required to complete a brief questionnaire (detailed hereafter). Those otherwise eligible were excluded if they failed to provide a urine sample for triclosan analysis. Four otherwise eligible participants who did not provide a satisfactory urine sample were thus excluded.
Institutional review board approval was obtained from each of the two hospital study sites. Recruitment ran from March through August 2012. Questionnaire completion and spot urine sample collection occurred immediately after a brief presentation about the project at various staff meetings on-site (these included educational events and standard staff meetings). After each presentation, health care workers were invited to participate. Altogether, 15 separate recruitment presentations were made at times ranging from 6 AM to 7 PM.
Exposure Questionnaire
We developed a brief survey questionnaire using an iterative process of review within the study team. Items on the timing of recent exposure took into account a triclosan half-life of approximately 11 hours; work exposure assessed the anticipated primary factor driving hand washing (patients directly cared for); and exposure to triclosancontaining personal product included toothpaste, given the efficiency of buccal absorption 23 (specifically eliciting use of the only brand of triclosan-containing toothpaste [TCT] on the US market, Colgate Total R ). In addition, because four of five liquid soaps contain triclosan, 3 home antibacterial soap use was also included, along with acne creams given their triclosan content. 24 The survey, although intentionally brief, did include items that also estimated potential exposure to phthalates to inform a future research project. The survey instrument exclusive of the phthalate items is available as an online supplement (http://links.lww.com/JOM/A157)
Laboratory Methods
The spot urine sample was collected in phthalate-and triclosan-free urine containers. Immediately after collection, urine samples (room temperature) were transported to the laboratory within 1 hour. Analysis of free and total triclosan in urine was carried out by liquid chromatography-tandem mass spectrometry. The limit of detection for both analytes is 0.05 μg/L. Quantitation of each analyte was done by isotope dilution method, using a 10-point calibration curve. Each analyte has a limit of quantitation of 0.1 μg/L. For details of the laboratory methods, see the online supplement (http://links.lww.com/JOM/A157).
Data Analysis
The mean and standard deviation for age and urinary creatinine were calculated for each hospital site stratum and for the entire cohort. We tested differences by using the t test for the age and the Wilcoxon test for the number of hours worked in the 48-hour period before participation and the creatinine. Differences in categorical variables were tested using the chi-square test. Descriptive statistics for triclosan levels (free, conjugated, and total) were calculated for each hospital site and for the entire study sample for all participants and for participants stratified by TCT use (because TCT was a major potential source of triclosan exposure, independent of hospital exposure). The overall differences in triclosan levels by hospital site and by TCT use analyzed together were tested by analysis of variance; pairwise comparisons used the Wilcoxon rank sum for median values and the t test for mean values. To facilitate comparison to national data (NHANES), 21 the geometric mean urinary triclosan levels adjusted for creatinine were calculated for the exposed and unexposed groups.
We performed a multiple linear regression analysis among all study participants to analyze the combined effects of TCT use and hospital exposure, adjusting for the covariates of age and urinary creatinine. To further assess the role of other cofactors and to take into account the differing mix by site of profession and sex, we reestimated the linear regression models stratified by site and further including in addition to the variables in the previous models profession, sex (men), the number of workplace hand washings in past 24 hours, time worked over the past 48 hours, and personal use of antibacterial soaps.
RESULTS
We studied 76 participants, 38 from each hospital site (Table 1 ). The mean age was 35 ± 9.6 years, the majority were women, and the study population was divided fairly equally among physicians and nurses. There were, however, significant demographic differences between those studied at the two hospitals. Participants from hospital 1 (which used triclosan-containing disinfectant soap) were 7.5 years older on average (P < 0.001) and included fewer physicians (13% vs 84%; P < 0.001). Although the hospital 1 group also had a higher proportion of women, this difference was not statistically significant. The nurses, compared with physicians, were less likely to be men, 4 of 39 (10.3%) compared with 15 of 37 (40.5%) (P < 0.01). Among the exposure cofactors of interest (Table 1) , there were no statistically significant differences by hospital site, although the use of TCT was more prevalent among participants at hospital 2. The median number of hours worked at hospital 1 in the previous 48 hours (median, 13) indicated sufficient time for occupational exposure at that site, as did the frequency of hand washing at work (median, 8; range, 0 to 40). Urinary creatinine, a marker of specimen concentration that might confound triclosan quantification, was similar in the two groups. Table 2 shows observed values for urinary triclosan by hospital site for free, conjugated, and total triclosan. Because the use of TCT was a potent potential source of triclosan exposure independent of hospital site, the data were further stratified by that factor. Overall, values of free triclosan were more than an order of magnitude lower than conjugated triclosan among both TCT and non-TCT users. Because of the dominance of conjugated relative to free values, total triclosan levels were quite similar to the conjugated levels. Of the six highest observed total urinary triclosan values (range, 416 to 505 ng/mL), three were from hospital 1 (one of these had coexposure to TCT) and three were from hospital 2 (all TCT users) (data not shown in the table).
Among non-TCT uses, the urinary concentrations of total (nonconjugated and conjugated combined) triclosan were significantly higher at hospital 1 compared to hospital 2 (median values 68.5 vs 8.6 ng/mL; P = 0.02). In contrast, among TCT users the concentrations were higher but quite similar by hospital (255 vs 258 ng/mL; P > 0.8). Among the two groups of TCT and non-TCT users combined, hospital 1 manifested higher levels than hospital 2, but this difference was not statistically significant. Free triclosan levels did not differ by hospital for either TCT stratum. All comparisons in Table 2 were tested nonparametrically; parametric testing, however, did not yield findings that were substantively different (data not shown). The geometric mean total triclosan level was 92.92 ng/mL for hospital 1 and 36.65 ng/mL for hospital 2. The overall mean free triclosan/urinary creatinine ratio (microgram per mg) was 0.04 ± 0.08 (median, 0.011); the mean conjugated value was 2.58 ± 5.0 (median, 0.85).
To analyze the combined effects of TCT use and potential exposure to triclosan through hand soap in hospital 1, we tested models including both of these two risk factors, also including as covariates age and urinary creatinine. The parameter estimates for TCT use and site of hospital employment are shown in Table 3 . Taking into account employment site, TCT use was associated with 142 and 146 ng/mL urine higher values for conjugated and total triclosan, respectively (P < 0.001). Working in hospital 1 was associated with a urine conjugated triclosan level of 205 ng/mL (P = 0.02) and a very similar estimate for total triclosan (206 ng/mL; P = 0.02). Use of TCT was associated with free triclosan (P = 0.051); hospital employment site was not statistically associated with free triclosan in the multivariate analysis.
Because of the intercorrelations among hospital site, profession (nurse vs physician), and sex, we sought to examine further TCT use and occupational exposure as predictors of urinary triclosan, stratified by hospital and taking into account other cofactors (Table 4) . There was no consistent pattern of association with the additional factors tested. The point estimate for the association of TCT with urinary free and conjugated triclosan was lower in hospital 1 and higher in hospital 2 (and statistically significant for conjugated triclosan in the latter). Being a nurse in hospital 1 was notable for an association with increased conjugated triclosan (P = 0.09), while male sex in hospital 1 was associated with a higher free triclosan (P = 0.052) level. Inclusion of all of the additional covariates in these analyses only marginally increased the explanatory power of the model as compared with the restricted model limited to TCT use, hospital site, age, and creatinine (as shown in Table 3 ): for free triclosan, model R 2 = 0.31 (vs 0.24); and conjugated triclosan, R 2 = 0.62 (vs 0.60). Moreover, the estimated intercepts in these models did not differ statistically from zero; that is, we could not exclude as a chance observation a detectable level of triclosan that would be present without any of the modeled risk factors.
DISCUSSION
To our knowledge, this is the first peer-reviewed biomonitoring study to measure triclosan levels among health care workers. The study underscores hospital exposure and use of TCT as important sources of exposure to triclosan. Among non-TCT users, there were significantly higher conjugated and total triclosan levels in those who worked in the hospital that used triclosan-containing soap in all patient care areas. In the hospital that did not use triclosan, TCT was the dominant contributor to the observed levels and, in the stratum of TCT users, obscured the differences between the two hospitals. Multivariate analysis, taking into account both TCT use and hospital, however, made it clear that both factors were independent predictors of the triclosan burden and that the occupational factor, overall, was associated with the largest estimated effect.
It is not surprising that TCT use correlated with higher urinary triclosan levels. Other studies have showed that buccal absorption of triclosan is high. For example, Allmyr and colleagues 23 reported that after brushing with 0.3% TCT for 14 days, subjects had triclosan blood levels that were increased by several orders of magnitude (from 0.009 to 0.81 ng/g preexposure to 26 to 296 ng/g after exposure; P = 0.003). Lin 25 measured blood levels of triclosan 4 hours after rinsing with 0.03% triclosan mouthwash and found that 7.5% of the total administered dose was absorbed.
Of interest, the free triclosan levels did not differ by hospital for any stratum. This may be due to a conjugation that occurs locally by skin cells, consistent with findings in a rat model. 26 Although conjugation also occurs in the liver, it is possible that dermal absorption does not contribute significantly to levels of free triclosan, thus explaining the pattern we observed.
As stated earlier, the geometric mean total urine triclosan was 92.92 ng/mL for the exposed and 36.65 ng/mL for the unexposed hospital. By comparison, a representative sample of the general US population for adults (20 years and older) in NHANES for the years 2009-2010 observed a geometric mean total urine triclosan level of 15.5 ng/mL (95% confidence interval, 12.9 to 18.5). 27 On the basis of those data, hospital 1 falls between the 75th and 90th percentile values of the NHANES data (61.8 and 262 ng/mL, respectively), whereas hospital 2 falls between the 50th and 75th percentile (11.1 and 61.8 ng/mL, respectively). Calafat et al 21 found that in NHANES data, higher levels were seen during the third decade of life and among people with the highest household income, and that levels did not vary by ethnicity/race or sex. Thus, the higher overall geometric mean levels that we observed may be explained, at least partially, by higher socioeconomic status and older age.
This study has several important limitations. A major limitation of this study design is its reliance on a cross-sectional, convenience sample of participants rather than employing an alternative design, such as a stratified random sample of the entire working populations of the two hospitals studied or, even more ideally, a crossover intervention trial in which triclosan-containing soap was allowed, removed, and then readded to the work environment. It is possible, for example, that those with the greatest triclosan exposure at work would be more concerned about their triclosan exposure levels and thus be more likely to participate, although this might also occur with randomly selected potential participants. Nonetheless, although this phenomenon might lead to an overestimate of exposure levels, it would not be likely to account for all of the hospital site-related effect that was observed. In addition, the sample size is small, especially in regard to the stratified analyses that might analyze possible interactions among risk factors. Because no preexisting validated questionnaire assessing exposure to triclosan among hospital workers was available, we developed de novo the survey instrument used in this investigation. Moreover, the survey was constrained by brevity, given the demanding work schedules of potential study participants. The relationship between the relevant exposure items and measured triclosan, however, supports the content validity of the survey. This study relied on participant recall of specific types of products used, which may have led to exposure misclassification. At the triclosan-exposed hospital, given two principal options for hand hygiene (water-free hand rub and the triclosan-containing soap), there were varying levels of exposure to triclosan. This was reflected in the wide range of reported hand washings with triclosancontaining soap while working in hospital 1. In addition, because of feasibility constraints, we did not measure serum triclosan levels, which would have required a phlebotomy protocol (and would also have been likely to hinder participation).
There are hundreds of triclosan-containing products, the use of which, for the sake of brevity, was not included in the questionnaire and participants may have had sources of triclosan exposure that were not accounted for. This was not likely to have made a large contribution, however, given that the intercept of the model estimates was not statistically different than zero, although larger sample size would have provided greater study power in that regard. We were also limited by our inability to set a fixed recruitment schedule that might have reduced the variability in time from last exposure until urine sampling. For example, because the half-life of triclosan is less than 12 hours, those with work exposure on a previous shift but not yet exposed on the day of measurement would tend to have lower levels of triclosan detected than might have been measured sooner postshift; similarly, exposure to TCT that occurred in the morning before work with sampling in the late afternoon might have had lower levels than had that person been sampled earlier. Nonetheless, although this effect to the extent present would have led to a lower estimate of effect, it should not have acted in a systematic way to account for the associations that we did observe.
Despite these limitations, our analysis has identified a role for occupational exposure in our participants' triclosan burden. Because biostatical modeling based on a relatively small convenience sample is constrained by wide confidence intervals, however, further biomonitoring studies with a larger sample size of randomly selected individuals would be necessary to confirm these results. This is all the more relevant because the effects of long-term, low-level human triclosan exposure are unknown, but in vivo and in vitro experimental data have raised serious questions regarding potential adverse endocrine and other effects. Moreover, at least one such analysis focusing on skeletal and cardiac muscle impairment in mice studied triclosan concentrations in a range that has been reported in humans. 15 These endocrine disrupting and myotoxic effects seen have yet to be evaluated in human studies, as therefore health effects in humans at current exposure levels remain unknown. Large-scale human studies at current exposure levels in vulnerable subpopulations such as the fetus or developing child have not been done and are unlikely to be performed, given feasibility constraints. Of note as well, beyond direct toxicity, there are also human and wider environmental concerns associated with triclosan. For example, there is evidence to suggest that the use of triclosan may contribute to antibiotic resistance among selected pathogenic microbes. 28 Furthermore, triclosan is biopersistent in the environment. The widespread, routine use of triclosan is called further into question in light of lack of proven antimicrobial efficacy for this chemical. A review of both microbial counts and infectious disease prevention found that, at typical concentrations, triclosan-containing soaps have no more efficacy than ordinary soap and water. 29 Until the clinical benefit weighted against any potential human adverse health and wider negative environmental effects of triclosan have been delineated more fully, it may be best to take a precautionary approach as elucidated by Kriebel et al: "when an activity raises threats of harm to human health or the environment, precautionary measures should be taken even if some cause and effect relationships are not fully established scientifically." 30 
